Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide

Thrombosis Research

Volumn 85, Issue 5, 1997, Pages 387-398

  Stephens, Alick C ^a   Rivers, Rodney P A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

antisense oligodeoxynucleotide; CD4; endocytosis; monocyte; tissue factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD14 ANTIGEN; MONOCYTE TISSUE FACTOR; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

BLOTTING, NORTHERN; FACTOR VII; FACTOR VIIA; FACTOR XA; HUMANS; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; THIONUCLEOTIDES; THROMBOPLASTIN;

EID: 0031104685     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00027-3     Document Type: Article

References (48)

1. CAMERER E., KOLSTO A-B, PRYDZ H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res. 81:(1):1996;1-41.
2. BACH R. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem. 23:1988;339-368.
3. NEMERSON Y. Tissue factor and hemostasis. Blood. 71:1988;1-8.
4. OSTERUD B., RAPAPORT SI. Activation of factor 1X by the reaction product of tissue factor and factor V11; additional pathways for initiating blood coagulation. Proc Natl Acad Sci USA. 74:1977;5260-5264.
5. CARSON SD, BROZNA JP. The role of tissue factor in the production of thrombin. Blood Coag Fibrinol. 4:1993;281-292.
6. EDGINGTON TS, MACKMAN N, BRAND K, RUF W. The structural biology of expression and function of tissue factor. Thromb Haemostas. 66:1991;67-79.
7. RIVERS RPA, HATHAWAY WE, WESTON WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 30:1975;311-316.
8. HETLAND O, BROVALD A-B, HOLME R, GAUDERNACK G, PRYDZ H. Thromboplastin (tissue factor) in plasma membranes of human monocytes. Biochem J. 228:1985;735-743.
9. LYBERG T. Clinical significance of increased thromboplastin activity on monocyte surface-a brief review. Haemostasis. 14:1984;430-439.
10. SCHORER AE, KAPLAN ME, RAQ GH, MOLDOW CF. Interleukin-1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemostas. 56:1986;256-259.
11. LYBERG T, GALDAL KS AND PRYDZ H. Synthesis of thromboplastin in endothelial cells. Second international symposium on the biology of the vascular endothelial cell, Cambridge, UK, (abstract No. 47) 1981.
12. GECZY CL, HOPPER KE. A mechanism of migration inhibition in delayed type hypersensitivity reactions. 11. Lymphokines promote procoagulant activity: enhancement of production in vitro by IgI and anti-body complexes. J Clin Invest. 59:1981;549-557.
13. KORNIBERG A, TREVES A, RACNILEWITZ EA, FIBACH E. Generation of procoagulant activity by phorbol ester-induced macrophages derived from a leukemic promyelocytic line (HL-60). Blood. 59:1982;1061-1066.
14. RIVERS RPA, CATTERMOLE HEJ, WRIGHT I. The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy. Ped Res. 31:1992;567-573.
15. RUF W, EDGINGTON TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 8:1994;385-390.
16. TAYLOR FB, CHANG A, RUF W, MORRISSEY JH, HINSHAW L, CATLETT R, BLICK K, EDGINGTON TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 33:1991;127-134.
17. LIPP P, SCHWALLER B, NIGGLI E. Specific inhibition of Na-Ca exchange function by antisense oligodeoxynucleotides. FEBS Lett. 364:1995;198-202.
18. ZHENG RQH, KEMENY DM. Inhibition of gene expression by anti-sense oligodeoxynucleotides. Clin Exp Immunol. 100:1995;380-382.
19. WANG S, LEE RJ, CAUCHON G, GORENSTEIN DG, LOW PS. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA. 92:1995;3318-3322.
20. GRAHAM FL, VAN DE EB A. A new technique for the assay of infectivity of human adenovirus IV DNA. Virology. 52:1973;456-467.
21. CARLOS MP, LEBKOWSKI JS, BOTCHAN MR. High mutation frequency in DNA transfected into mammalian cells. Proc. Natl. Acad. Sci. USA. 80:1983;3015-3019.
22. KEOWN WA, CAMBELL CR, AND KUCHERLAPTI RS. Methods for introducing DNA into mammalian cells. In D.V. Goeddel (ed.), Methods in Enzymology 185, Academic Press, New York 527-537, 1990.
23. FELGNER PL, GADEK TR, HOLM M, ROMAN R, CHAN HW, WENZ M, NORTHROP JP, RINGOLD GM, DANIELSEN M. Lipofectin: a highly efficient lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
24. PETTENAZZO A, JOBE A, IKEGAMI M, ABRA R, HOGUE E, MIHALKO P. Clearance of phosphatidylcholine and cholesterol from liposomes, liposome loaded with metaproterenol, and rabbit surfactant from adult rabbit lungs. Am. Rev. Respir. Dis. 139:1989;752-758.
25. MEISNER D, PRINGLE J, MEZEI M. Liposomal pulmonary drug delivery. J. Microencap. 6:1989;379-387.
26. SCHWARTZ AL. Receptor cell biology: receptor-mediated endocytosis. Pediatr Res. 38:1995;835-843.
27. ZIEGLER-HEITBROCK HWL, ULEVITCH RJ. CD14: Cell surface receptor and differentiation marker. Immunol. Today. 14:1993;121-125.
28. STEPHENS AC, ZHENG RQH, BEDFORD-RUSSELL AR, LEVINE M, RIVERS RPA. Production of tissue factory by monocyte progenitor cells. Thromb Res. 76:1994;33-45.
29. STEPHENS AC, ZHENG RQH, RIVERS RPA. Co-localization of tissue factor protein and its mRNA in human blood monocytes. Thromb Res. 81:1996;545-554.
30. JUNG G, KOHNLEIN GW, LUDERS G. Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-Succinimidyl 3-(2-pyridyldithio) proprionate. Biochem. Biophys. Res. Commun. 101:1981;599-606.
31. SCARPATI E.M., WEN D, BROZE G.J. JR., MILETICH J.P., FLANDERMEYER R.R., SIEGEL N.R., SADLER J.E. Human tissue factor: cDNA sequence and chromosome localisation of the gene. Biochemistry. 26:1987;5234-5238.
32. ANDREWS B, REHEMTULLA A, FOWLER B, EDGINGTON T, MACKMAN N. Conservation of tissue factor primary sequence among three mammalian species. Gene. 98:1991;265-269.
33. ANDREWS B. Is the wks motif the tissue-factor binding site for coagulation factor VII. TIBS. 16:1991;31-36.
34. RIORDAN JR, ROMMENS JM, KEREM B-S, ALON N, ROZMAHEL R, GRZELCZAK J, LOK S, PLAVSIC N, CHOU J-L, DRUMM ML, IANNUZZI MC, COLLINS FS, TSUI L-C. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1989;1066-1073.
35. BOYUM A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 21:(97):1968;77-89.
36. ZUCKERMAN SH, ACKERMAN SK, DOUGLAS SD. Long term peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell culture. Immunology. 38:1979;401-411.
37. MORITZ B, AND LANG H. A novel chromogenic assay for Factor V11. Annuls Hematol. 64, (suppl), A23, 1992.
38. MANIATIST T, FRITSCH E.F, AND SAMBROOK J. Molecular cloning: A Laboratory Manual. pp 312-322, Cold Spring Harbor Laboratory, Cold Spring Harbor. N.Y 1983.
39. WHITE BA, BANCROFT FC. Cytoplasmic dot hybridization: Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol. Chem. 257:1982;8569-8572.
40. WAGNER RW. Gene inhibition using antisense oligodeoxynucleotides. Nature. 372:1994;333-335.
41. OSTERUD B, FLAEGSTAD T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis. Thromb Haemost. 49:(1):1983;5-7.
42. KJAEVE J, OSTERUD B, BJERTNAES L. The function of granulocytes and alveolar macrophages following a single dose of endotoxin in rabbits. Effects of methylprednisolone. Acta Anaesthesiol Scand. 34:(8):1990;619-623.
43. WILCOX JN, SMITH KM, SCHWARTZ SM, GORDON D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 86:(8):1989;2839-2843.
44. EDWARDS RL, LEVINE JB, GREEN R, DUFFY M, MATHEWS E, BRANDE W, RICKLES FR. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology. 92:(2):1987;329-337.
45. EDWARDS RL, RICKLES FR, CRONLUND M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med. 98:(6):1981;917-928.
46. LEATHAM EW, BATH PM, TOOZE JA, CAMM AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 73:(1):1995;10-13.
47. CROOKE ST. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol. 32:1992;329-376.
48. 100 Escherichia coli in the baboon. Haemostasis. 26:(1):1996;83-91.